Skip to main content
Toggle navigation
Search
Home
Icon Legend
Back
373 Views
0
Like
Facebook
Tweet
Print
A Case Based Discussion: Individualizing Localized Prostate Cancer Treatment Decisions with the Oncotype DX® GPS™ Assay
Friday, May 13, 2022
9:30 AM – 10:30 AM
Location: S&T Hall: Booth 1043
Presenter(s)
EU
Edward M. Uchio, MD, FACS
Daniel Arthur Shoskes, MD
Cleveland Clinic
SC
Steven Canfield, MD
Learning Objectives:
Understand the importance of assessing risk of adverse pathology in making treatment decisions for localized prostate cancer.
Review the development of the Oncotype DX Genomic Prostate Score® (GPS™) assay
Understand how experts use the GPS assay to help inform management and treatment decisions in localized prostate cancer patients
Sponsored by: Exact Sciences / Oncotype DX